About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Bias And How to Deal With It | Main | Potassium Iodide Pills »

March 15, 2011

Quick Japan Update

Email This Entry

Posted by Derek

Just a quick note that the Japanese chemist I mentioned a couple of days ago, my old colleague Masanori Yamaura, has reported in. He and his family made it through the quake (he reports that his labs are pretty well trashed, though), and they're now evacuating Iwaki City due to the nuclear plant problems up the coast. A bit of good news, at a time when there isn't a whole bunch of it around.

Comments (5) + TrackBacks (0) | Category: Current Events


1. daen on March 15, 2011 10:51 PM writes...

That's great, Derek.

Permalink to Comment

2. Rick on March 15, 2011 11:26 PM writes...

Great news. We can use some of that.

Permalink to Comment

3. Jason on March 16, 2011 12:54 AM writes...

Well, there hasn't been anywhere near 100% casualties, so I imagine on the level of people affected, there are many happy, relieved stories.

There are many tragedies in Japan right now, but there are just as many here in the part of world not rocked by earthquake and tsunami. Tragedy and comedy are the eternal human condition.

Love your blog, Derek. Your writing is so clear. Thanks.

Permalink to Comment

4. Still Scared of Inflatable Iguanas on March 16, 2011 8:25 AM writes...

Excellent! Thanks for posting this info for all of us.

Permalink to Comment

5. RB Woodweird on March 16, 2011 9:14 AM writes...

In 1995 I made a very expensive reagent for a Japanese customer. About a month after they got it, they called to ask if we could make another batch. As first I thought it just worked really really well, but it turned out they hadn't even gotten a chance to open it up. It was stored in a refrigerator in one of their labs in Kobe.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry